Skip to main content

Feature article – SOCMA comes full circle

4th September 2020

Submitted by:

Andrew Warmington

SOCMA has acquired the Specialty & Custom Chemicals show. We spoke to CEO Jennifer Abril to find out why

The US trade association SOCMA has purchased the Specialty & Custom Chemicals America show and made an industry event a key part of its offer for the first time in 15 years. There was a time, of course, when an industry event was basically what SOCMA did.

Back in 1985, SOCMA started InformEx as a small-scale event for the US speciality and custom chemicals sector. It grew steadily to become a full-scale convention lasting for 3.5 days and typically attracting 4,000+ visitors to a show floor with some 500 booths.

“At its pinnacle in the early 2000s, InformEx was the event for the industry to attend,” says SOCMA CEO Jennifer Abril. “In a way it was a victim of its own success. It outgrew the ability of a trade association to handle, so it made sense for us to hand it on to an expert in the field.” For this reason, SOCMA sold InformEx to CMP in 2005, though it retained an advisory role.

Meanwhile, former InformEx sales manager Tom Leahy launched first the Specialty & Agro Chemicals America show in 2012, which now takes place in Charleston, South Carolina, in September. In 2018, Specialty & Custom Chemicals America was launched in Fort Worth, Texas. Both have been known informally as ‘Chemicals America’.

A new format

The format of these events derived from Leahy’s discussions with the industry. They are very different to what InformEx had become, being based on standard-sized, tabletop booths, free-to-attend educational sessions, low costs, networking opportunities and restricting the exhibitor base to companies headquartered in, or at least with a substantial presence in, the US.

Thanks in part to the ‘reshoring’ trend of recent years, both shows have become outstanding successes. SOCMA partnered with Leahy from the outset and, says Abril, ultimately buying the Fort Worth show was “something we contemplated from the beginning. It turns out that 2020, following on from initial growth, was the right time for both buyer and seller”.

Selling InformEx, she adds, did not take away from SOCMA’s role as a commercial connector for the industry, which it regards as its key function. However, it did leave more of a gap than SOCMA had realised at the time. “After these 15 years, this has become the critical missing piece that will enable our association to become whole again.”

Abril characterises what SOCMA will be doing from now on as a kind of inverted pyramid. At the bottom, are the lead sheets that help match companies’ project needs and capabilities. Next comes its newly launched manufacturing solutions database, a search engine through which users can find specific equipment and chemistries offered by members.

A further level up is the business-to-business platform, through which individual businesses can find each other in a more pinpointed way. The top level from now on will be the (renamed) Specialty & Custom Chemicals America Show, where businesses can come together each year in a show environment.

Plans for transition

Many SOCMA members, Abril notes, have said that the Chemicals America shows feel quite like InformEx used to be in terms of intimacy and its community feel. Thus, while SOCMA will seek to grow the Specialty & Custom Chemicals Show, “we will only grow it to the extent that it works for the industry”.

“Our objective is not to have something of the size and scale of InformEx as it used to be, but to ensure we are maximising the right attendees and the right exhibitors each year. What it already has is what makes it attractive to SOCMA,” she says.

For the 2021 show, which will kick off SOCMA’s 100th anniversary year, the association will continue to work with Leahy during the transition period. There will be “limited adjustments” to the format, reflecting safety protocols and other considerations during the COVID-19 pandemic. SOCMA will work with the authorities, the venue and others to find ways to enable face-to-face encounters to continue.

In the longer term, any change in format will be incremental and based on input from an advisory group of SOCMA members, Abril says. Other venues may be used – probably in the Texas-Louisiana area that houses so much of the US custom chemical sector – but the most important driver is to remain in the first quarter of the calendar year, counterbalancing the Charleston event and other East Coast shows.

State of business

COVID-19 is obviously having a huge impact on the chemicals industry in the US, as everywhere, SOCMA has found. How its member companies are faring is varying heavily from sector to sector.

Broadly speaking, Abril says, Q1 was strong across the board. Those SOCMA members who were well-positioned to serve industries that were absolutely essential to addressing the pandemic, like pharmaceuticals, medical devices, household cleaning products and antimicrobials, did particularly well.

Business in Q2 was largely dependent on the sector, and some were slightly off while others were stable in Q3. Some companies were concerned about a potential cliff in 2H because the horizon ahead was so unclear, but that did not materialise. Sales were softer in the middle of the year, but not drastically so. Some companies are looking at a strong end to 2020 and Q1 of 2021, and some are now saying they need to refill their pipelines.

“For the most part, we believe that most companies will find themselves close to what the projections for 2020 were at the start of the year,” Abril concludes.

Contact

Jenny Gaines

Senior Director, Communications & Engagement

SOCMA

+1 571 348 5150

[email protected]

www.socma.org

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

Drug product centre opens

Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona.

Submitted by:

Andrew Warmington

Evonik realigns Health Care

In order to “maximise customer centricity and market focus” and continue an ongoing transition into “a system solutions partner for the pharmaceutical and biotech industries”, Evonik has divided it

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington